SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-016713
Filing Date
2021-05-10
Accepted
2021-05-10 21:06:56
Documents
2
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 2105
2 EXHIBIT 24 brhc10024160_ex24.htm EX-24 11733
  Complete submission text file 0001140361-21-016713.txt   15179
Mailing Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151
Business Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151 519.322.8800
Tilray, Inc. (Issuer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O TILRAY, INC. 745 FIFTH AVENUE, SUITE 160 NEW YORK NY 10151
Business Address
Meiers James R. (Reporting) CIK: 0001860603 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38594 | Film No.: 21909286